Array BioPharma and Genentech Expand Oncology Collaboration

Array BioPharma today announced an expansion of a collaboration agreement with Genentech to develop small molecule drugs against an additional protein target in the field of oncology. The original collaboration, which began in January 2004, was formed to advance two of Array's proprietary oncology programs into clinical development. Under the expanded agreement, Array will receive additional research funding, as well as research and development milestone payments and product royalties based on the success of the new program.

BioSpace (http://www.biospace.com/news_story.cfm?StoryID=19628020&full=1)